Steven M. Greenberg, MD, PhD, FAHA, Chair; Wendy C. Ziai, MD, MPH, FAHA, Vice Chair;
Charlotte Cordonnier, MD, PhD; Dar Dowlatshahi, MD, PhD, FAHA; Brandon Francis, MD …

Pulmonary embolism (PE) remains a major contributor to global disease burden. Risk-
adapted treatment and follow-up contributes to a favorable outcome. Age-adjusted cutoff …

Background This is the 2nd update to the 9th edition of these guidelines. We provide
recommendations on 17 PICO (Population, Intervention, Comparator, Outcome) questions …

Background We update recommendations on 12 topics that were in the 9th edition of these
guidelines, and address 3 new topics. Methods We generate strong (Grade 1) and weak …

The task of developing ESC Guidelines covers not only the integration of the most recent
research, but also the creation of educational tools and implementation programmes for the …

Importance Although retrievable inferior vena cava filters are frequently used in addition to
anticoagulation in patients with acute venous thromboembolism, their benefit-risk ratio is …

Background: Despite advances in hospital management in recent years, it is not clear
whether mortality after acute pulmonary embolism (PE) has decreased over time. Objectives …

Venous thromboembolism (VTE) is the second leading cause of death in patients with
cancer. These patients are at a high risk of VTE recurrence and bleeding during …

Venous thromboembolism (VTE), including deep vein thrombosis (DVT) and pulmonary
embolism (PE), is a preventable cause of in-hospital death, and one of the most prevalent …

Background: Inferior vena cava (IVC) filters are widely used for prevention of pulmonary
embolism (PE). However, uncertainty persists about their efficacy and safety. Objectives: The …